eBooks Press Release -- NEWS
Bentham's Latest Book: Frontiers in Clinical Drug Research -- HIV: Volume 4
News Release Date: April 22, 2019
This book is Authored by: Paulo Jacomo Negro, Published on: February 26, 2019.
Frontiers in Clinical Drug Research – HIV is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the book series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research.
The fourth volume of this series features 5 chapters that cover these topics:
About the Author:
Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1142 international publications in several fields of organic chemistry including 775 research publications, 43 international patents, 70 chapters in books and 253 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products "Studies in Natural Product Chemistry" 60 volumes of which have been published under his Editorship by Elsevier during the last two decades.
Keywords: HIV, AIDS, Virology, HIV-1 Protease Inhibitors, HIV Medicine, Retrovirus, HAART, Antiretroviral Therapy, Magnetic Nanotherapeutics, neuroAIDS, Chemokine Receptor-Based HIV Entry Inhibitors, reverse transcriptase inhibitors, HIV-1 protease inhibitors, HIV prevention, Integrase Inhibitor, Sexually Transmitted Co-infections HIV-1 Replication Blocking, antiretroviral resistance, antiretroviral efficacy, Antiretroviral drugs.